APA (7th ed.) Citation

Jahn, A., Rump, A., Widmann, T. J., Heining, C., Horak, P., Hutter, B., . . . Klink, B. (2022). Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers. Annals of oncology, 33(11), . https://doi.org/10.1016/j.annonc.2022.07.008

Chicago Style (17th ed.) Citation

Jahn, Arne, et al. "Comprehensive Cancer Predisposition Testing Within the Prospective MASTER Trial Identifies Hereditary Cancer Patients and Supports Treatment Decisions for Rare Cancers." Annals of Oncology 33, no. 11 (2022). https://doi.org/10.1016/j.annonc.2022.07.008.

MLA (9th ed.) Citation

Jahn, Arne, et al. "Comprehensive Cancer Predisposition Testing Within the Prospective MASTER Trial Identifies Hereditary Cancer Patients and Supports Treatment Decisions for Rare Cancers." Annals of Oncology, vol. 33, no. 11, 2022, https://doi.org/10.1016/j.annonc.2022.07.008.